Literature DB >> 9103425

Contribution of CpG motifs to the immunogenicity of DNA vaccines.

D M Klinman1, G Yamshchikov, Y Ishigatsubo.   

Abstract

We previously showed that bacterial DNA contains immunostimulatory motifs consisting of unmethylated CpG dinucleotides flanked by two 5' purines and two 3' pyrimidines. These motifs rapidly trigger an innate immune response, characterized by the production of IL-6, IL-12, and IFN-gamma. Since DNA vaccines are constructed from plasmids of bacterial DNA, we examined whether CpG motifs present in these plasmids contributed to the immunogenicity of DNA vaccines. In vitro experiments showed that DNA plasmids induced production of the same cytokines stimulated by bacterial DNA, an effect eliminated by DNase treatment. In vivo experiments showed that the immunogenicity of a DNA vaccine was significantly reduced by methylating its CpG motifs and was significantly increased by coadministering exogenous CpG-containing DNA. These findings support the conclusion that CpG motifs in the plasmid backbone of DNA vaccines play an important role in the induction of Ag-specific immunity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9103425

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  96 in total

Review 1.  The influence of base sequence on the immunostimulatory properties of DNA.

Authors:  D S Pisetsky
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Antiviral protection after DNA vaccination is short lived and not enhanced by CpG DNA.

Authors:  S Oehen; T Junt; C López-Macías; T A Kramps
Journal:  Immunology       Date:  2000-02       Impact factor: 7.397

Review 3.  The response of human B lymphocytes to oligodeoxynucleotides.

Authors:  H Liang; P E Lipsky
Journal:  Springer Semin Immunopathol       Date:  2000

Review 4.  Activation of the innate immune system by CpG oligodeoxynucleotides: immunoprotective activity and safety.

Authors:  D M Klinman; S Kamstrup; D Verthelyi; I Gursel; K J Ishii; F Takeshita; M Gursel
Journal:  Springer Semin Immunopathol       Date:  2000

Review 5.  Pre-priming: a novel approach to DNA-based vaccination and immunomodulation.

Authors:  H Kobayashi; A A Horner; E Martin-Orozco; E Raz
Journal:  Springer Semin Immunopathol       Date:  2000

Review 6.  The role of CpG in DNA vaccines.

Authors:  M J McCluskie; R D Weeratna; H L Davis
Journal:  Springer Semin Immunopathol       Date:  2000

Review 7.  Nucleic acid vaccines: tasks and tactics.

Authors:  B S McKenzie; A J Corbett; J L Brady; C M Dyer; R A Strugnell; S J Kent; D R Kramer; J S Boyle; A M Lew
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

8.  Immunization onto bare skin with synthetic peptides: immunomodulation with a CpG-containing oligodeoxynucleotide and effective priming of influenza virus-specific CD4+ T cells.

Authors:  Anne-Sophie Beignon; Jean-Paul Briand; Sylviane Muller; Charalambos D Partidos
Journal:  Immunology       Date:  2002-02       Impact factor: 7.397

Review 9.  Physical trauma of vaccination acts as a wake-up call to dangers in the skin.

Authors:  Fiona J Culley; Wieslawa Olszewska
Journal:  Immunology       Date:  2003-11       Impact factor: 7.397

Review 10.  Technologies for enhanced efficacy of DNA vaccines.

Authors:  Fadi Saade; Nikolai Petrovsky
Journal:  Expert Rev Vaccines       Date:  2012-02       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.